Application of SBA-15 mesoporous material as the carrier for drug formulation systems. Papaverine hydrochloride adsorption and release study

Powder Technology

Volumn 230, Issue , 2012, Pages 106-111

  Moritz, Michal ^a   Laniecki, Marek ^a  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

Drug delivery; Drug release kinetics; Drug reservoir; Mesoporous materials; Phosphodiesterase inhibitor

Indexed keywords

ACTIVE SUBSTANCE; BET SURFACE AREA; DRUG FORMULATIONS; DRUG RELEASE; DRUG RELEASE KINETICS; DRUG RESERVOIR; HIGH PRESSURE; HYDROXYPROPYL CELLULOSE; MESOPOROUS; PHOSPHODIESTERASE INHIBITORS; SLOW DIFFUSION;

ADSORPTION; CELLULOSE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY; GRANULATION; ORGANIC POLYMERS; STEARIC ACID; THERMOGRAVIMETRIC ANALYSIS; X RAY DIFFRACTION;

MESOPOROUS MATERIALS;

DRUG CARRIER; HYDROXYPROPYLCELLULOSE; PAPAVERINE; SBA 15; STEARIC ACID; UNCLASSIFIED DRUG;

ARTICLE; DESORPTION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ADSORPTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG GRANULE; DRUG RELEASE; HYDROPHOBICITY; ISOTHERM; POROSITY; POWDER; SYNTHESIS; TABLET; TABLET FORMULATION; THERMOGRAVIMETRY; X RAY DIFFRACTION;

EID: 84865166221     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2012.06.061     Document Type: Article

References (46)

1. Dash A.K., Cudwarth G.C. Therapeutic applications of implantable drug delivery systems. Journal of Pharmacological and Toxicological Methods 1998, 40:1-12.
2. Raj N.K.K., Deshpandale S.S., Ingle R.H., Raja T., Manikandan P. Heterogenized molybdovanadophosphoric acid on amine-functionalized SBA-15 for selective oxidation of alkenes. Catalysis Letters 2004, 98:217-224.
3. Zhang X., Yue Y., Gao Z. Chromium oxide supported on mesoporous SBA-15 as propane dehydrogenation and oxidative dehydrogenation catalysts. Catalysis Letters 2002, 83:19-25.
4. Wang S. Ordered mesoporous materials for drug delivery. Microporous and Mesoporous Materials 2009, 117:1-9.
5. Vallet-Regí M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angewandte Chemie International Edition 2007, 46:7548-7558.
6. 2 solids for the treatment of temporal lobe epilepsy. Optical Materials 2006, 29:75-81.
7. Díaz A., López T., Manjarrez J., Basaldella E., Martinez-Blanes J.M., Odriozola J.A. Growth of hydroxyapatite in a biocompatible mesoporous ordered silica. Acta Biomaterialia 2006, 2:173-179.
8. Hudson S.P., Padera R.F., Langer R., Kohane D.S. The biocompatibility of mesoporous silicates. Biomaterials 2009, 29:4045-4055.
9. Sonwane C.G., Ludovice P.J. A note on micro- and mesoporous in the walls of SBA-15 and hysteresis of adsorption isotherms. Journal of Molecular Catalysis A: Chemical 2005, 238:135-137.
10. Vallet-Regí M., Ramila A., del Real R.P., Pérez-Pariente J. A new property of MCM-41: drug delivery system. Chemistry of Materials 2001, 13:308-311.
11. Doadrio A.L., Doadrio J.C., Sánchez-Montero J.M., Salinas A.J., Vallet-Regí M. A rational explanation of the vancomycin release from SBA-15 and its derivative by molecular modeling. Microporous and Mesoporous Materials 2010, 132:559-566.
12. Vallet-Regí M., Doadrio J.C., Doadrio A.L., Izquierto-Barba I., Pérez-Pariente J. Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin. Solid State Ionics 2004, 172:435-439.
13. 1 from mesoporous silica tablets. Journal of Controlled Release 2007, 119:215-221.
14. Halamová D., Badaničowá M., Zeleňák V., Gondová T., Vainio U. Naproxen drug delivery using periodic mesoporous silica SBA-15. Applied Surface Science 2010, 256:6489-6494.
15. Charnay C., Begu S., Tourne-Peteilh C., Nicole L., Lerner D.A., Devoisselle J.M. Inclusion of ibuprofen in mesoporous templated silica drug loading and release property. European Journal of Pharmaceutics and Biopharmaceutics 2004, 57:533-540.
16. Xu W., Gao Q., Xu Y., Wu D., Sun Y., Shen W., Deng F. Controllable release of ibuprofen from size-adjustable and surface hydrophobic mesoporous silica spheres. Powder Technology 2009, 191:13-20.
17. Moritz M., Łaniecki M. Modified SBA-15 as the carrier for metoprolol and papaverine: adsorption and release study. Journal of Solid State Chemistry 2011, 184:1761-1767.
18. Qu F., Zhu G., Huang S., Li S., Sun J., Zhang D., Qiu S. Controlled release of captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous and Mesoporous Materials 2006, 92:1-9.
19. Park S.-Y., Pendleton P. Mesoporous silica SBA-15 for natural antimicrobial delivery. Powder Technology 2012, 223:77-82.
20. Lu Y., Go Y., Wang Y., Liu X., Wang Y., Guo Y., Zhang Z., Lu G. Immobilized penicillin G acylase on mesoporous silica: the influence of pore size, pore volume and mesophases. Microporous and Mesoporous Materials 2008, 114:507-510.
21. Balas F., Manzano M., Colilla M., Vallet-Regí M. L-Trp adsorption into silica mesoporous materials to promote bone formation. Acta Biomaterialia 2008, 4:514-522.
22. Xu W., Gao Q., Xu Y., Wu D., Sun Y., Shen W., Deng F. Controlled drug release from bifunctionalized mesoporous silica. Journal of Solid State Chemistry 2008, 181:2837-2844.
23. Vallet-Regi M., Balas F., Collila M., Manzano M. Bioceramics and pharmaceuticals: a remarkable synergy. Solid State Sciences 2007, 9:768-776.
24. Doadrio J.C., Sousa E.M.B., Izquierdo-Barba I., Doadrio A.L., Perez-Pariente J., Vallet-Regí M. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. Journal of Materials Chemistry 2006, 16:462-466.
25. Zhu Y., Shi J. A mesoporous core-shell structure for pH-controlled storage and release of water-soluble drug. Microporous and Mesoporous Materials 2007, 103:243-249.
26. Xu W., Gao Q., Xu Y., Wu D., Sun Y. pH-controlled drug release from mesoporous silica tablets coated with hydroxypropyl methylcellulose phthalate. Materials Research Bulletin 2009, 44:606-612.
27. Mal N.K., Fujiwara M., Tanaka Y., Taguchi T., Matsukata M. Photo-switched storage and release of guest molecules in the pore void of coumarin-modified MCM-41. Chemistry of Materials 2003, 15:3385-3394.
28. Zhu Y., Kaskel S., Ikoma T., Hanagata N. Magnetic SBA-15/poly(N-isopropylacrylamide) composite: preparation, characterisation and temperature-responsive drug release property. Microporous and Mesoporous Materials 2009, 123:107-112.
29. Sarawade P.B., Kim J.-K., Hilonga A., Kim H.T. Preparation of hydrophobic mesoporous silica powder with a high specific surface area by surface modification of a wet-gel slurry and spray-drying. Powder Technology 2010, 197:288-294.
30. Gao Y.J., Stead S., Lee R.K.M.W. Papaverine induces apoptosis in vascular endothelial and smooth muscle cells. Life Sciences 2002, 70:2675-2685.
31. Carhuapoma J.R., Qureshi A.I., Tamargo R.J., Mathis J.M., Hanley D.F. Intra-arterial papaverine-induced seizures: case report and review of the literature. Surgical Neurology 2001, 55:159-163.
32. Kim E.D., El-Rashidy R., McVary K.T. Papaverine topical gel for treatment of erectile dysfunction. The Journal of Urology 1995, 153:361-365.
33. Lebeau P., Janot M.M. Traité de Pharmacie Chimique 1956, Masson et C1e Editeurs, Paris, Tome IV. VIem edition.
34. Zhao D., Huo Q., Feng J., Chmelka B.F., Stucky G.D. Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures. Journal of the American Chemical Society 1998, 120:6024-6036.
35. Mellaerts R., Houthoofd K., Elen K., Chen H., Van Speybroeck M., Van Humbeeck J., Augustijns P., Mullens J., Van den Mooter G., Martens J.A. Aging behavior of pharmaceutical formulation of itraconazole on SBA-15 ordered mesoporous silica carrier material. Microporous and Mesoporous Materials 2010, 130:154-161.
36. Meynen V., Cool P., Vansant E.F. Verified syntheses of mesoporous materials. Microporous and Mesoporous Materials 2009, 125:170-223.
37. Ghedini E., Signoretto M., Pinna F., Crocella V., Bertinetti L., Cerrato G. Controlled release of metoprolol tartrate from nanoporous silica matrices. Microporous and Mesoporous Materials 2010, 132:258-267.
38. Izquierdo-Barba I., Collila M., Manzano M., Vallet-Regí M. In vitro stability of SBA-15 under physiological conditions. Microporous and Mesoporous Materials 2010, 132:442-452.
39. Chytil S., Haugland L., Blekkan E.A. On the mechanical stability of mesoporous silica SBA-15. Microporous and Mesoporous Materials 2008, 111:134-142.
40. Van Der Voort P., Ravikovitch P.I., De Jong K.P., Benjelloun M., Van Bavel E., Janssen A.H., Neimark A.V., Weckhuysen B.M., Vansant E.F. A new templated ordered structure with combined micro- and mesopores and internal silica nanocapsules. The Journal of Physical Chemistry. B 2002, 106:5873-5877.
41. Doadrio A.L., Sousa E.M.B., Doadrio J.C., Pérez-Pariente J., Izquierdo-Barba I., Vallet-Regí M. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. Journal of Controlled Release 2004, 97:125-132.
42. Costa P., Lobo J.M.S. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences 2001, 13:123-133.
43. Fagundes L.B., Sousa T.G.F., Sousa A., Silva V.V., Sousa E.M.B. SBA-15-collagen hybrid material for drug delivery application. Journal of Non-Crystalline Solids 2006, 352:3496-3501.
44. Miyajima M., Koshika A., Okada J., Ikeda M., Nishimura K. Effect of polymer crystallinity on papaverine release from poly (l-lactic acid) matrix. Journal of Controlled Release 1997, 49:207-215.
45. Espinoza R., Hong E., Villafuerte L. Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets. International Journal of Pharmaceutics 2000, 201:165-173.
46. Tatavarti A.S., Mehta K.A., Augsburger L.L., Hoag S.W. Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices. Journal of Pharmaceutical Sciences 2004, 93:2319-2331.